Histamine 2 Antagonists
Definition
Histamine 2 antagonists are drugs that block the production of acid in the stomach.
Purpose
Histamine 2 antagonists are used to treat the precancerous condition of Barrett's esophagus. They are also used to treat Zollinger-Ellison syndrome and multiple endocrine neoplasia, rare cancerous conditions in which the stomach makes too much acid and to prevent the development of gastric (stomach) and duodenal (upper part of the small intestine) ulcers.
Description
Histamine 2 blockers are familiar to most people as the over-the counter heartburn medications Tagamet (cimetidine), Pepcid, (famotidine), and Zantac (ranitidine). Axid (nizatidine) is less well known. These drugs also come in prescription strengths. Histamine 2 blockers work by reducing the amount of acid the stomach produces.
The esophagus is a tube 10-13 inches long and about 1 inch wide that carries food from the mouth to the stomach. Normally, the esophagus is lined with cells that are similar to skin cells and look smooth and pinkish-white.
The stomach makes acid to help digest food. A different type of cell that is resistant to acid lines the stomach. These cells look red and velvety. At the place where the esophagus meets the stomach, there is a ring of muscle called a sphincter that normally keeps acid stomach juices from backflowing into the esophagus. When this sphincter is not working correctly, stomach acid enters the bottom portion of the esophagus. This backflow is called reflux or heartburn. When reflux occurs frequently over an extended period of time, it is called gastroesophageal reflux disease (GERD).
Barrett's esophagus is pre-cancerous condition in which normal cells lining the esophagus are repeatedly exposed to stomach acid and are replaced with abnormal cells that, in some people, develop into a type of cancer of the esophagus called adenocarcinoma. Histamine 2 blockers are given to reduce acid in the stomach and eliminate exposure of the esophagus cells to acid.
Histamine 2 blockers are also used to treat two rare cancerous conditions: multiple endocrine neoplasia (MEN) and Zollinger-Ellison syndrome, both of which can cause the stomach to produce too much acid. In MEN, an inherited form of cancer, tumors form in more than one gland. Depending on which glands are affected, the stomach may be stimulated to produce excess acid. In Zollinger-Ellison syndrome, a tumor in the digestive tract secretes a hormone called gastrin that stimulates the production of stomach acid. These tumors are malignant (cancerous) in 50% to 65% of people with Zollinger-Ellison syndrome.
Histamine 2 blockers are sometimes given in advance of chemotherapy to help reduce the gastrointestinal side effects of chemotherapy drugs. Cimetidine was the first histamine 2 blocker approved by the United States Food and Drug Administration (FDA) in 1976.
